Our response to COVID-19

We're supporting people to maintain their wellbeing and manage isolation.

media room

NEWS AND MEDIA

Researchers recommend used child safety seats are thoroughly inspected

Researchers have found that despite heavy use, sun exposure, and general wear and tear, older child safety seats still perform well in simulated frontal crashes. The findings by NeuRA researchers at the Transurban Road Safety Centre show that older restraints will protect a child occupant in a crash, providing they have not already been in a serious road accident. The researchers found that some restraints were damaged during the testing in a way that would impair their performance in any subsequent crashes. “In our laboratory crash testing, we found that these seats were effective in protecting child passengers from head…

Researchers open the door to new schizophrenia treatment

Newly published research has identified the biological changes that cause the negative symptoms and psychosis that people with schizophrenia experience. This discovery has significant implications for schizophrenia treatments, which to date have not been able to target these debilitating side effects. Current schizophrenia treatments only address psychotic symptoms some of the time, and do not restore people to their full potential. As a result, approximately 80 per cent of people with schizophrenia are left unemployed and many alone. But the newly published study by Neuroscience Research Australia (NeuRA) may help to change this as it uncovers precisely where problematic biological changes…

Pain research using virtual reality receives $A5 million from the US Department of Defence

Research that is being co-led by NeuRA and UNSW Sydney has been awarded $A5 million for a project that will use virtual reality to ease nerve-related pain following spinal cord injury. Granted by the US Department of Defence, the funding will enable researchers to assess whether a novel virtual reality walking intervention can effectively reduce spinal cord injury neuropathic pain. Neuropathic pain affects approximately 60 per cent of people with spinal cord injury and is described as burning, sharp and unremitting. In addition to being unbearable, neuropathic pain rarely responds to medication or alternative treatments. Patients that do choose drugs…

New Spinal Cord Injury Research Centre offers new hope and treatment discoveries

Neuroscience Research Australia (NeuRA) has today opened Australia’s new Spinal Cord Injury Research Centre. The Centre will house the latest cutting edge technology and accelerate Australia’s research into better treatment for those with a spinal cord injury. At the Centre’s opening, it was announced NeuRA researchers will receive $6.4 million in NSW Government funding for projects aimed at providing better treatments for people with spinal cord injuries. The Centre’s projects involve using the latest research breakthroughs, such as virtual reality and electrical stimulation to restore feeling, movement and function after a devastating injury. NeuRA CEO Professor Peter Schofield AO said…

NeuRA and Transurban announce new three-year partnership

NeuRA and Transurban are proud to announce a new three-year partnership to support the operations of the Transurban Road Safety Centre at NeuRA. The Transurban Road Safety Centre (TRSC) conducts research on how injuries occur on our roads, and how to prevent these injuries by improving safety equipment and ensuring it is used optimally. During the first three-year partnership between Transurban and NeuRA, several important milestones were achieved. These included the building of the TRSC in 2017, which became Australia’s first research-dedicated crash test lab. The TRSC’s crash sled enables researchers to test a myriad of simulated road accidents, providing…

Associate Professor Tony Roscioli receives Federal Government funding

A research project that will examine the feasibility of genomic testing has received funding from the Australian federal Government Medical Research Futures Fund (MRFF). The two-year project, PreGen, will be led by Associate Professor Tony Roscioli, who is an expert in genomics at Neuroscience Research Australia (NeuRA), UNSW and New South Wales Health Pathology. The funding received will allow PreGen to perform genomic tests in families seen at 10 of Australia’s largest maternity centres. This will assess the benefits made available from antenatal genomic testing. “We do not currently have easily accessible accredited antenatal genomic testing in Australia. Pregnancy abnormalities…